Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 September 2020: Animal Study

Efficacy, Drug Sensitivity, and Safety of a Chronic Ocular Hypertension Rat Model Established Using a Single Intracameral Injection of Hydrogel into the Anterior Chamber

Huan Yu 1BCE* , Huimin Zhong 2CDF* , Junjue Chen 1DF , Jun Sun 1BF , Ping Huang 3EF , Xing Xu 3CE , Shouyue Huang 1ADE , Yisheng Zhong 1AG*

DOI: 10.12659/MSM.925852

Med Sci Monit 2020; 26:e925852

Figure 2 Changes of intraocular pressure (IOP) after a first administration of ocular hypotensive agents. The results showed that brimonidine, timolol, brinzolamide, and bimatoprost eye drops had an ocular hypotensive effect on rats with elevated IOP. IOP of brimonidine-treated and timolol-treated groups was reduced to a minimum level at 2 h after administration, and then slightly rebounding, but was still significantly lower than that of the model control group at 24 h after administration (P<0.05). The effect of bimatoprost was not obvious within 6 h after administration. The IOP was reduced at 8 h after administration and maintained at that level until 24 h. The IOP of the rats treated with brinzolamide was reduced to the lowest at 4 h after administration, and then gradually increased. The IOP at 6 h after administration was not significantly different from that of the control group (P>0.05). IOP returned to pre-dose levels at 8 h after administration. The ocular hypotensive effect of pilocarpine in this model was not obvious.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750